CASI Pharmaceuticals Inc.

NASDAQ: CASI · Real-Time Price · USD
2.15
-0.02 (-0.92%)
At close: Aug 20, 2025, 10:29 AM

CASI Pharmaceuticals Revenue

CASI Pharmaceuticals reported an annual revenue of $28.54M, reflecting a -15.77% growth. For the quarter ending March 31, 2025, CASI Pharmaceuticals generated $6.24M in revenue.
Revenue (ttm)
28.54M
Revenue Growth
-15.77%
Price / Sales Ratio
1.52
Revenue / Employee
122.48K
Employees
233
Market Cap
33.31M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 28.54M -15.77%
Dec 31, 2023 33.88M -21.41%
Dec 31, 2022 43.11M +42.89%
Dec 31, 2021 30.17M +99.25%
Dec 31, 2020 15.14M +266.52%
Dec 31, 2019 4.13M +Infinity%
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Dec 31, 2016 0 -100.00%
Dec 31, 2015 47.71K +101.09%
Dec 31, 2014 23.73K +Infinity%
Dec 31, 2013 0 -100.00%
Dec 31, 2012 669.31K -65.52%
Dec 31, 2011 1.94M -47.45%
Dec 31, 2010 3.69M -30.11%
Dec 31, 2009 5.28M -29.33%
Dec 31, 2008 7.48M +1.10%
Dec 31, 2007 7.4M +7.27%
Dec 31, 2006 6.89M +16.50%
Dec 31, 2005 5.92M +1051.38%
Dec 31, 2004 514K -67.38%
Dec 31, 2003 1.58M +33.92%
Dec 31, 2002 1.18M -36.81%
Dec 31, 2001 1.86M -49.29%
Dec 31, 2000 3.67M -26.56%
Dec 31, 1999 5M -3.85%
Dec 31, 1998 5.2M +8.33%
Dec 31, 1997 4.8M +9.09%
Dec 31, 1996 4.4M +511.11%
Dec 31, 1995 720K +700.00%
Dec 31, 1994 90K +Infinity%
Dec 31, 1993 0 n/a
Dec 31, 1992 0 n/a
Dec 31, 1991 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.